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Cancer is a public health problem the 
world over. The malignancies of the female 
genital organs are major causes of morbidity and 
mortality. This is particularly so in the 
developing countries where there is poor 
awareness and late presentation. Worldwide, 
gynaecological cancers account for about 10% 
of new cancer cases in women and 12% of 
1cancer deaths . Developed countries have seen a 
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ABSTRACT
Context: Female cancer is a public health problem the world over. The malignancies of the female genital 
organs are major causes of morbidity and mortality which necessitates data for policy formulation and 
health planning. 
Objective: To document the relative frequency, age distribution and histological patterns of gynaecological 
malignancies seen at the Jos University Teaching Hospital (JUTH).
Methodology: A retrospective 5 year review of all gynaecological malignancies seen at the JUTH.
Main outcome measures: frequency, age distribution and histological patterns of gynaecological 
malignancies
Result: Female genital tract cancers account for 5.4% of gynaecological disorders in JUTH. The complete 
records of 203 out of 250 patients with gynaecological malignancies were retrieved giving a retrieval rate of 
81.2%. Of these 203 case records, 152(74.9%) cases were from the uterine cervix while 31(15.3%) and 
13(6.5%) cases were from the ovary and uterine corpus respectively. The vagina and vulva accounted for 
3(1.4%) and 4(1.9%) cases respectively. Squamous cell carcinoma accounted for 93.4% of cervical cancers 
and 100% of vaginal and vulval cancers. Epithelial tumours accounted for 61% of ovarian tumours while 
choriocarcinoma accounted for 53.8% of cancers of the corpus uteri.
Conclusion: Squamous cell cervical cancer is still the most common gynaecological malignancy in Jos. The 
challenges of HIV/AIDS and cervical screening need to be addressed to reduce its incidence.
Keywords: Gynaecological cancers, pattern, frequency, histology, Jos
INTRODUCTION 
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decline in cervical cancer due to organized 
1,2
screening programmes . However, in sub-
Saharan Africa, squamous cell carcinoma of the 
cervix accounts for the largest proportion of 
3-8
genital tract cancers . 
Endometrial carcinoma has become the 
most common female genital tract malignancy 
in North America and Northern Europe while it 
is less commonly seen amongst Nigerian 
1,3,9
women . Ovarian cancer is one of the 
common female genital tract malignancies with 
considerable geographical variation, the 
incidence in the highest risk countries being 
five times greater than that in the lowest risk 
10-12
countries .Vulval and vaginal cancers are rare 
th 3,13-15
with peak incidence in the 6  decade of life .  
There has been limited recent 
information on the pattern of gynaecological 
cancers in Jos hence the decision to carry out 
this study to determine the frequency and 
pattern of gynaecological malignancies and if 
there are any significant changes from previous 
reports at the Jos University Teaching Hospital, 
Jos. This could have significant implications on 
health planning and policy decisions.
MATERIALS AND METHODS:
This was a retrospective descriptive 
study carried out at the Jos University Teaching 
Hospital, Jos, North Central Nigeria. The age, 
clinical and histological diagnoses of all 
consecutive patients with gynaecological 
malignancies managed between January, 1999 
and December, 2003 were retrieved from the 
ward case notes, theatre records and 
histopathology records of the University of Jos 
Teaching Hospital and entered into prepared 
proformas.
The analysis of data was done using simple 
percentages. 
RESULTS:
During the 5-year period under review there 
were 250 patients with gynaecological 
malignancy out of 4606 new patients seen in the 
gynaecological outpatient clinic giving an 
incidence of 5.4%. However the complete 
records of only 203 patients were retrieved for 
analysis giving a retrieval rate of 81.2%.
Relative frequencies of gynaecological 
malignancies: Majority of gynaecological 
malignancies (74.9%) were from the uterine 
cervix while vaginal and vulval cancers were 
rare (Table 1). 
Age range/Mean age: The youngest age for 
gynaecological cancers was for ovarian cancer, 
choriocarcinoma and cervical cancer: 19, 20 and 
23years respectively (Table 1). The mean age at 
presentation was lowest for choriocarcinoma 
(29.7 years) while vaginal and vulval cancers 
had the highest mean ages of 61.7 and 65 years 
respectively (Table 1).
Histological pattern: The histological types of 
all gynaecological tumours are shown in table 2. 
Squamous cell carcinoma was the most common 
cancer of the cervix (93.4%). Choriocarcinoma 
accounted for the largest proportion of uterine 
cancers (53.8%) while epithelial tumours  were 
the most common type of ovarian cancer 
(61.3%) with serous cyst adenocarcinoma 
accounting for the largest proportion (Table 2). 
All vulval and vaginal cancers were squamous 
cell carcinomas (Table 2).
DISCUSSION:
        The main findings of the study were that 
gynaecological cancers account for a significant 
proportion (5.4%) of the gynaecological disease 
burden and the pattern of gynaecological 
cancers is similar to the report 10 years ago from 
the same institution with cervical cancer as the 
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most common malignancy. 
 Carcinoma of the uterine cervix accounted for 
152 (74.9%) cases. This is similar to findings 
from other parts of Nigeria and sub-Saharan 
countries which showed cervical cancer to be 
the commonest malignancy of the female 
genital tract with squamous cell carcinoma 
accounting for 85-90% of primary cervical 
1,4,5,7,8,14-16
neoplasia . This is due primarily to the 
limited availability and poor uptake of cervical 
screening facilities prevalent in most 
17,18
developing countries . The mean age of 
cervical cancer was 39.5 years which was lower 
than 49 to 55 years reported from other parts of 
4,5,7,8
Nigeria and sub-Saharan Africa . It is also 
lower than the mean age of 50years reported 10 
6
years ago from our institution . This may be 
largely due to the increased presence of HIV 
seropositivity which has been found to increase 
the incidence of cervical cancer and at a 
19
younger age .
Ovarian cancer was the second 
commonest malignancy in our study, 
accounting for 15.3% of gynaecological 
malignancies which is similar to 16.3% in 
Maiduguri differs from 24% and 26.3% 
1,16,20
reported from Nnewi and Kano . It was also 
the second most common gynaecological 
1,16,20
malignancy from these centres . The 
commonest ovarian cancer in our study was the 
e p i t h e l i a l  t y p e  o f  w h i c h  s e r o u s  
cystadenocarcinoma was the commonest 
variety. This is similar to findings from other 
1,16,20,21
centres in Nigeria . Ovarian cancer is more 
common in the industrialized than in the non-
industrialized world. The highest reported 
incidence rates are from Sweden, Norway and 
other affluent countries, whereas the lowest are 
3
from Japan and other Asian countries . The 
observed decreased risk with increasing parity 
 
and breast-feeding may explain the lower 
22
incidence of ovarian cancer in our women .
Choriocarcinoma represents 53.8% of all 
tumours of the uterine corpus similar to 54.1% 
14
reported in Maiduguri . However, it constitutes 
only 3.45% of all gynaecological malignancies 
in this study which is similar to previous  reports 
 6,14,15
and other centres in Nigeria .  It was found to 
have an age range of 20-40years (mean 
29.7years) because it is a disease that occurs in 
women of reproductive age. However, 
endometrial cancer and other malignant lesions 
of the corpus uteri were less commonly seen, a 
fact that may be related to the level of socio-
economic development in the society. In 
epidemiological terms, it is widely accepted that 
cancer of the corpus uteri is a disease of affluent 
societies, with incidence rates closely 
correlating with a nation's gross domestic 
23
product .
 Vaginal and vulval tumours are generally rare as 
documented in this study where they constituted 
1.4 % and 1.9% of tumours. Similar findings 
have been reported from Ghana, Malawi and 
4,5,16,24
other centres in Nigeria . All vaginal and 
vulval tumours were of squamous cell origin 
which correlates previous reports from Jos and 
1,6,16,24
findings from other studies  . 
The limitations of the study was that it 
was retrospective with the problems associated 
with such studies especially difficulty in 
obtaining all the required data. It is also a 
hospital based study and may not be a true 
representation of the general population. 
However, with the problems of poor record 
keeping and poor hospital utilization, the 
information from the study is necessary for 
policy and health planning and also forms a basis 
for further research.              
Gynaecological malignancies contribute 
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a significant portion to the gynaecological 
disease burden in JUTH and the pattern of these 
malignancies is similar to the previous reports 
from our hospital with cervical cancer 
accounting for a vast majority of cases. This is 
probably an indication that the problems of 
cervical screening has not yet been addressed 
and the emergence of HIV/AIDS has worsened 
the problems of cervical cancer in our 
environment. There is therefore the need for 
better organization of cervical screening 
programmes. There is also need for proper 
record keeping with the strengthening of the 
cancer registry system so that the magnitude of 
the problem of cancers can be better appreciated 
and resources better allocated to tackle the 
challenges of cancer in Nigeria while 
strengthening the primary healthcare centres so 
that community based awareness, screening 
and research can be properly done.


















































Vagina 3 1.4 55-70 61.7
Total 203 100
Table 2 : Site and histological p attern of gynaecological malignancies
Histological type Number of patients Percentage (%)
Cervix




























































   
Dysgerminoma 3 9.7
Endometrial sinus tumour 2 6.4
Immature teratoma 1 3.2
Mature cystic teratoma with malignant 
transformation
1 3.2
Mature cystic teratoma with malignant 
transformation
1 3.2
Sex cord stromal tumours
  

























Squamous cell carcinoma 4 100
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